Aandeel RECIPHARM PUBL AB
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Recipharm publ AB Swiss Exchange

Aandelen

SE0005757267

slotkoers Swiss Exchange
Andere beurzen
- SEK - Intraday-grafiek van Recipharm publ AB
2023 Synokem Pharmaceuticals Limited verwierf 74% belang in Nitin Lifesciences Limited van Recipharm AB (publ). CI
2023 Recipharm kondigt wijzigingen aan in CEO CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Åsa Bergström New COO at Nanologica AB (publ)
Blue Wolf Capital to Acquire OSD CDMO Sites from Recipharm
Blue Wolf Capital Partners LLC agreed to acquire Seven manufacturing and development facilities of Recipharm AB.
Recipharm attains major sustainability milestones
Recipharm, Medspray, and Resyca enter into exclusive license agreement to develop nasally-delivered drug products using proprietary soft mist technology
ReciBioPharm partners with Acuitas Therapeutics to provide rapid technology transfers and CGMP manufacture of Acuitas LNP formulations
Recipharm announces collaboration with Oz-UK to accelerate the development of low global warming potential pMDIs utilising HFA-152a propellant
Synokem Pharmaceuticals Limited acquired 74% stake in Nitin Lifesciences Limited from Recipharm AB.
Recipharm Announces CEO Changes
Recipharm Appoints Marc Funk as Board of Directors
Marc Funk to transition to Recipharm's Board of Directors, Greg Behar appointed new CEO, Inhaled Business to standalone in 2024
Fitch Affirm Recipharm at 'B'; Outlook Stable.
Recipharm - Earthquake in Morocco
Recipharm partners with Ahead Therapeutics to develop rare autoimmune disease therapy
Recipharm Announces Executive Appointments
Recipharm and Honeywell to speed development of inhalers with a near-zero global warming potential propellant
Recipharm's new analytical lab brings impressive testing capabilities to global markets
NewBiologix SA announced that it has received CHF 45 million in funding from Recipharm AB and other investors
Recipharm Appoints Vikas Gupta as President of ReciBioPharm
Arranta Bio, a Recipharm company, signs contract with MIT to develop rapid manufacturing of mRNA therapeutics
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers RECI B
  4. Koers
  5. Nieuws Recipharm publ AB
  6. Andere talen